TY - JOUR
T1 - Pioglitazone and the risk of myocardial infarction and other major adverse cardiac events: a meta-analysis of randomized, controlled trials.
AU - Nagajothi, Nagapradeep
AU - Adigopula, Sasikanth
AU - Balamuthusamy, Saravanan
AU - Velazquez-Cecena, Jose-Luis E
AU - Raghunathan, Kalpana
AU - Khraisat, Ahmad
AU - Singh, Sarabjeet
AU - Molnar, Janos
AU - Khosla, Sandeep
AU - Benatar, Daniel
N1 - A recent meta-analysis suggested that the use of rosiglitazone increases the risk of myocardial infarction (MI) in patients with type 2 diabetes mellitus. It is unclear whether this is a class effect of thiazolidinediones (TZD). We did a meta-analysis to evaluate cardiovascular outcomes with the use ...
PY - 2008/11/1
Y1 - 2008/11/1
UR - https://www.ncbi.nlm.nih.gov/pubmed/19127132
U2 - 10.1097/MJT.0B013E318167180C
DO - 10.1097/MJT.0B013E318167180C
M3 - Article
SN - 1536-3686
VL - 15
JO - American Journal of Therapeutics
JF - American Journal of Therapeutics
IS - 6
ER -